Home › NDC Lookup › RxCUI directory › RxCUI 308351

2.5 ML argatroban 100 MG/ML Injection — RxCUI 308351

RxNorm drug concept · Semantic clinical drug
RxCUI 308351 Semantic clinical drug · SCD ● Current RxNorm concept 7 FDA products 7 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI308351
Official name2.5 ML argatroban 100 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asargatroban 250 MG per 2.5 ML Injection; argatroban 250 MG in 2.5 ML Injection
FDA products mapped7
Package NDCs mapped7
Reported Medicaid activity (SDUD)35 prescriptions · 1 state & territory Medicaid programs · latest period Q3 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Argatroban: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Argatroban is used when heparin has caused a serious reaction called heparin-induced thrombocytopenia, or HIT. In HIT, your immune system reacts to heparin in a way that actually t...
  • Why am I getting argatroban instead of regular heparin?
  • Yes, you'll be awake. Argatroban is given as a slow, continuous drip through an IV line directly into your vein. It's always given in a hospital or clinical setting by your care te...
  • How will I receive argatroban, and will I be awake during treatment?
📖 Read our full Argatroban guide →

🕸️ Concept Web — How 2.5 ML argatroban 100 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 2.5 ML argatroban 100 MG/ML Injection RxCUI 308351

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Argatroban 15202
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Argatroban Injection 1804730
    • Argatroban Injectable Product 1158258
    • Injection 1649574
    • Injectable Product 1151126
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Argatroban 100 MG/ML 329284

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Argatroban 100 MG/ML SCDC · 329284
  • Argatroban Injection SCDF · 1804730
  • Argatroban Injectable Product SCDG · 1158258

📦 FDA Products & Package NDCs

7 products · 7 package NDCs
7 package NDCs map to RxCUI 308351 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00143-9288-01 1 VIAL in 1 CARTON (0143-9288-01) / 2.5 mL in 1 VIAL Argatroban Hikma Pharmaceuticals USA Inc. 2012-01-05
00143-9559-01 1 VIAL in 1 CARTON (0143-9559-01) / 50 mL in 1 VIAL Argatroban Hikma Pharmaceuticals USA Inc. 2016-11-01
00143-9674-01 2.5 mL in 1 VIAL (0143-9674-01) Argatroban Hikma Pharmaceuticals USA Inc. 2012-01-05
42023-0182-01 1 VIAL in 1 CARTON (42023-182-01) / 2.5 mL in 1 VIAL Argatroban Par Health USA, LLC 2015-06-01
42023-0182-89 1 VIAL in 1 CARTON (42023-182-89) / 2.5 mL in 1 VIAL Argatroban Par Health USA, LLC 2015-06-01
67457-0212-02 1 VIAL, GLASS in 1 CARTON (67457-212-02) / 2.5 mL in 1 VIAL... Argatroban Mylan Institutional LLC 2017-11-14
70121-1037-01 1 VIAL, GLASS in 1 CARTON (70121-1037-1) / 2.5 mL in 1 VIAL... Argatroban Amneal Pharmaceuticals LLC 2018-01-26
Observed labelers: Hikma Pharmaceuticals USA Inc. (3) · Par Health USA, LLC (2) · Amneal Pharmaceuticals LLC (1) · Mylan Institutional LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J0883 Argatroban nonesrd use 1mg 5 CMS
J0884 Argatroban esrd dialysis 1mg 5 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.